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INTRODUCTION
In  the  last  few  decades,  kidney  transplantation  has  evolved  into  a  practical 
therapeutic modality for the management of chronic renal failure1; but along with the 
realized dream of a successful renal allograft come the harsh reality of a plethora of 
opportunistic infections due to the necessity of immunosuppression.
Infections remain the most  important  cause of  morbidity  and mortality  among 
renal transplant recipients. In tropical countries like India, there are numerous factors 
like hot and humid climate, lack of hygiene practices, poor socioeconomic status, and 
the  endemic  nature  of  certain  infections  contribute  to  their  high  incidence2,  besides 
immunosuppression, which is the major factor.
The lung has special vulnerability to infection. Respiratory tract infections have 
been  implicated  as  the  single  largest  cause  of  infection  related  mortality  in  renal 
transplant  recipients3.  Appropriate  treatment  at  the  right  time  of  post  transplant 
respiratory infections could save these patients. This requires the knowledge about the 
spectrum of microorganisms causing these infections and the time of development of 
such respiratory  tract  infections.  Aggressive  diagnostic  approaches  including various 
tests are required to make an early diagnosis and to start appropriate treatment.
The  present  study  was  undertaken  to  know  about  the  etiological  factors  for 
respiratory  infections  in  post  renal  transplant  patients,  their  common  clinical 
presentation, and the role of bronchoalveolar lavage in its diagnosis.
AIM OF THE STUDY
1. To  study the  spectrum of  bacterial,  mycobacterial  and  fungal  infections  of 
lower  respiratory  tract  and  their  sensitivity  pattern  in  post  renal  transplant 
patients.
2.   To document the common mode of clinical presentation for respiratory tract 
infection in post renal transplant patients.
 
REVIEW OF LITERATURE
 Microbial spectrum
A host of microbes, ranging from common viral and bacterial pathogens to exotic 
fungal and protozoal agents, has been reported to cause pulmonary infections in the 
immunocompromised host.
 World wide status
Bacteria: During the early years of transplantation, aerobic gram negative bacilli 
(Escherichia  coli,  Pseudomonas  aeruginosa and  Klebsiella  pneumoniae)  and 
Staphylococcus aureus were frequent causes of pneumonia in renal allograft recipients4. 
These  pathogens  are  commonly  hospital  acquired  and  are  responsible  for  a  high 
mortality rate. In some transplant centers, these bacteria and Streptococcus pneumoniae 
still remain the most important causes of pneumonia5. As the pathological diagnosis is 
difficult to establish by sputum analysis alone, management depends on recovery of the 
causative organisms from blood culture, trans-tracheal aspirate and/or a bronchoscopy 
specimen utilizing a sheathed brush. 
Mycobacterium tuberculosis- Renal transplant patients have an increased risk of 
pulmonary  infection  due  to  Mycobacterium tuberculosis and atypical  mycobacteria6. 
Because of the compromised host defense status of these patients, disseminated infection 
is common. Unusual pulmonary presentations may be seen in transplant patients with 
tuberculosis and to further complicate matters, a prior history of tuberculosis exposure 
or  a  positive  tuberculin  test  may  not  be  obtained.  Thus,  the  index  of  suspicion  of 
mycobacterial  infection  must  always  remain  high  in  renal  transplant  patients  with 
pulmonary infiltrates. If expectorated sputum is negative by acid fast stain, fiberoptic 
bronchoscopy should be considered to obtain adequate specimens for repeat staining as 
well as mycobacterial culture.
Fungi: During  the  early  years  of  transplantation,  fungi  were  recognized  as  a 
common and highly lethal  group of  pathogens in transplant  recipients.  Although the 
incidence of fungal pneumonia has declined significantly, this disease remains one of the 
most serious infections in renal transplant recipients7. The four major fungal etiologies 
of  pneumonia  to  be  considered  in  renal  allograft  recipients  are  Aspergillus  species, 
Histoplasma capsulatum,  Coccidiodes immitis and  Cryptococcus neoformans;  several 
epidemologic  and  clinical  features  can  be  helpful  in  distinguishing  among  these. 
Aspergillosis  is  usually  acquired  in  the  hospital  and  often  closely  follows 
cytomegalovirus  disease  while  Coccidioidomycosis  and  histoplasmosis  are  generally 
restricted to areas of endemic infection. Although disseminated disease is common to all 
pulmonary  mycoses,  cryptococcosis  and  histoplasmosis  frequently  present  without 
obvious pulmonary involvement.
Pneumocystis carinii  -   P. carinii pneumonia may accompany other infections in 
patients treated with immunosuppressants but can itself cause respiratory insufficiency 
and death8. The classic pattern is readily recognized and can usually be diagnosed on the 
basis of the patient’s history, physical examination and chest radiography. These patients 
usually  have  severe  shortness  of  breath,  low grade  fever  and  a  dry,  non-productive 
cough.  The  degree  of  dyspnea  far  exceeds  the  other  toxic  signs  and  there  may  be 
cyanosis in the absence of any sputum or fever.  There is a diffuse bilateral  alveolar 
infiltrate extending from the hilum to the very periphery of the lung. This pneumonia 
consists  of  thick  proteinaceous  intra-alveolar  exudates  composed  primarily  of  the 
organisms themselves. If recognized early, this condition can be treated and cured, since 
it may run an indolent course. The GMS stain (Gomori methenamine silver stain) was 
used for confirmation, and BAL is the method of choice for diagnosis.
Munda et al (1976) recorded forty six episodes of pulmonary infection in 41 
patients during a seven year study period in which 187 renal transplants were 
performed9. Five patients had two episodes of pulmonary infection each. Twenty four 
patients recovered and seventeen died (41.5%). The etiologic agents diagnosed were 
primarily bacterial (74%), with protozoa, fungi and viruses appearing less frequently. In 
35 episodes, a single etiologic agent was found but 11 were caused by two or more 
agents.
In a study by Huertas et al (1976), pneumonia developed in 33 of the 266 renal 
transplant recipients while they were on immunosuppressive therapy10. The majority of 
cases was bacterial in origin and developed during the first two postoperative weeks. 
Cases of fungal pneumonia were fewer and developed later. The mortality was 51.5% 
for  all  cases  of  pneumonia.  The  organisms  identified  were  K.  pneumoniae (30%), 
Enterobacteriaceae (30%), S. fecalis (24%), H. influenzae (24%), P. aeruginosa (21%), 
E.  coli (18%),  A. fumigatus (15%),  H.  parainfluenzae (12%),  P.  mirabilis (9%),  P. 
carinii (9%), S. aureus (9%), P. morgagnii (6%), CMV (6%), Herellea (6%), C. albicans 
(3%), Serratia (3%).
Stake  et  al  (1976)  analysed  pulmonary  complications  in  77  renal  transplant 
patients11.  They found complications to be significantly higher in men. The mortality 
rate due to these chest infections was 14%. They found the causative organisms to be 
bacteria, Pneumocystis carinii, CMV and fungi.
 Webb et al, in 1978, studied 68 episodes of pulmonary complications in 52 of 416 
renal transplant patients treated with low dose immunosuppression12. They found 44 
infectious complications with 75% of these being wholly bacterial. Eight (18%) patients 
died of chest infections of which 7 had bacterial pneumonia but other infections were 
also present in 5.
Marshall et al13 (1980), in a retrospective review of 101 renal transplant cases, 
identified 14 cases of Legionnaires’ disease. In 1984, Gombert et al14 also described five 
cases of nosocomial legionellosis in renal transplant recipients. Legionellosis was 
confirmed by seroconversion or direct fluorescent antibody. 
 Heurlin et al (1989) carried out a two year study of pneumonia in renal transplant 
recipients15. The microbiologic etiology of pneumonia in 34 renal transplant patients 
with clinical and x ray evidence of pulmonary parenchymal disease was studied. CMV 
was found to be the most common etiology (18 cases), bacterial pneumonia was seen in 
11 patients, Pneumocystis carinii in 4 patients and Candida albicans in one patient. The 
overall mortality was 32%.
Hall et al16 (1994) retrospectively reviewed case records of renal transplant 
recipients from 1980 to 1992 to determine the prevalence and presentation of 
mycobacterial infection. They found 22 cases of mycobacterial infection in 487 patients 
with 21 cases being confirmed as M. tuberculosis and 1 unidentified Mycobacterium 
other than tuberculosis.
Kalender et al17 (2000) retrospectively evaluated opportunistic pulmonary 
infection in 274 kidney graft recipients from 1986 to 1998. They found the causes to be: 
pulmonary tuberculosis in 17 (42.5%) cases, aspergillosis in 8 (20%), CMV in 5 
(12.5%), nocardiosis in 3 (7.5%, mucormycosis in 1 (2.5%) and unknown in 6 (15%).
The results of other studies from western countries are given in the following 
table .
Table No.1 Spectrum of pulmonary infection in studies from 
western countries (%)31
Munda
1978
Webb 
1978
Willcox
1990
Sternbeg
1993
Edelstein 
1995
Episodes 46 44 48 58 32
Bacteria 69.5 68.8 37.5 25.8 71.9
Nocardia 2.1 13.6 6.2 1.7 0
M. tub 4.3 2.2 22.9 0 28.1
P. carinii 13.0 6.8 8.3 10.3 0
Fungi 13.0 13.6 6.2 3.4 0
CMV 15.2 9.1 4.1 22.4 0
Others 2.1 0 6.2 3.4 0
Indian scenario
In the West, serious infections were noted in about 70% of the patients undergoing 
transplantation, with a near 40% fatal outcome18. Advances in diagnosis, prevention and 
therapy have reduced the mortality to less than 5% in developed countries19, 20. In 
contrast, the lack of transplant registries has resulted in a dearth of information on the 
etiology and course of post transplant infections in tropical countries2like India Most of 
the available data are based on the experience of individual physicians from a limited 
number of centers. It is estimated that infections complicate the course of 50-70% of 
transplant recipients in tropical countries, with mortality ranging from 20-60%21. The 
factors contributing to this dismal outcome include unhygienic conditions, hot and 
humid climate, late presentation, a lack of knowledge about the spectrum of organisms 
in these areas and high cost of life saving antimicrobial agents2. The pattern of infections 
among transplant recipients in a tropical environment like ours differs from that seen in 
regions with temperate climate.
Bacterial  infections: Among  renal  transplant  recipients,  bacterial  infections 
originate  most  commonly  from  the  lungs  and  the  urinary  tract  22.  The  causative 
organisms are the same as those prevalent in the general population. The etiologic agent 
often  remains  unidentified  because  of  unavailability  of  isolation  techniques  and 
physicians  tent  to  start  broad spectrum antibiotics  on  empirical  grounds.  Pulmonary 
nocardial  infections  have  been  documented  with  a  lower  frequency  among  renal 
transplant recipients in the tropical regions. Similarly, legionella, an important cause of 
post transplant pneumonia in the temperate climate, has not been reported2. In part, this 
discrepancy could be accentuated by the lack of awareness and unavailability of specific 
diagnostic techniques in the regions.
Mycobacterium tuberculosis: Because of its endemicity and the protean ways in 
which this disease can present, tuberculosis remains a frequent infection among renal 
transplant patients2. Compared to the incidence of less than 1% in the United States and 
Europe and 4% in the Middle East, this infection is encountered in 10-13% of all renal 
transplant recipients in the tropical regions23. Jha et al observed tuberculosis in 11.8% of 
patients 2. The commonest presentation among transplant recipients in the tropics is with 
pleuropulmonary disease. About 20-40% patients present  with fever of undetermined 
aetiology24.  The  diagnosis  is  often  made  retrospectively  after  observing  a  complete 
response  to  antitubercular  therapy.  Although  M.  tuberculosis is  the  most  common 
species isolated from these patients, infection with atypical Mycobacteria such as  M. 
kansasii,  M.  marinum,  M.  avium-intracellulare and  M.  fortuitum has  also  been 
documented23. Since these organisms are much less sensitive than M. tuberculosis to the 
conventional antitubercular agents, the species identification by culturing the specimen 
on appropriate media assumes considerable importance. Tuberculosis presents numerous 
diagnostic  difficulties  in  renal  transplant  recipients.  The  classic  picture  of  apical 
involvement on chest X ray is seen in only a minority of the allograft recipients, and 
now bronchoalveolar lavage has been shown to be useful in making an early accurate 
diagnosis of tuberculosis in this group of patients. 
Fungal infections: Candida infection involves the lungs, usually as a secondary 
invader in those with a pre-existing infective or non-infective pulmonary lesion2. The 
diagnosis is made by demonstrating the organism on BAL using a sheathed catheter. 
Sputum  culture  is  not  diagnostic  because  of  the  possibility  of  contamination  with 
pharyngeal secretions where this organism usually resides. Pulmonary aspergillosis has 
been  reported  in  a  significant  proportion  of  renal  transplant  recipients  in  tropical 
countries25. Patients present with necrotising bronchopneumonia or, less commonly, with 
involvement of nasal sinuses. Zygomycosis can take the form of fulminant rhinocerebral 
disease or necrotising pneumonia with massive haemoptysis26.
Pneumocystis carinii: Before the introduction of cotrimoxazole prophylaxis, 
about 5-10% renal transplant recipients were observed to develop pneumonia due to P. 
carinii18, 27. The frequency is higher in those on cyclosporine and the period of greatest 
risk is between 1 and 6 months after transplantation. Occasional clustering of cases has 
been reported in the tropical regions28. Interstitial pneumonia leading to respiratory 
failure is a cardinal feature and the mortality approaches 60-100% in those with this 
complication.
 Agarwal et al (1992) studied the spectrum of tuberculosis in renal transplant 
recipients in northern India29. Of the 200 patients of end stage renal disease subjected to 
renal transplantation, 8 had pulmonary tuberculosis in the pre-transplant period. 11 
patients developed tuberculosis for the first time during post transplant period. Only one 
case had reactivation of tuberculosis.
 Sakhuja et al (1996) reported on the high incidence of tuberculosis among renal 
transplant recipients in India24. They found 36 cases of tuberculosis in 305 renal 
transplant recipients over a period of 8 years. The infection was limited to the thoracic 
cavity in 41.7% cases and disseminated in 27.8% cases. Only one site (11.1%) was 
extrapulmonary. Most of the cases were encountered in the first post transplant year.
Jha R et al (1999) carried out a retrospective study analyzing pulmonary 
infections after kidney transplant30. Out of 142 consecutive renal transplant recipients 
who underwent live donor transplantation from June 1990 to May 1998, 27 had 
pulmonary infections. The aetiologic agents according to this study were Gram negative 
bacteria (2), Gram positive bacteria (2), nocardia (2), tuberculosis (10), aspergillosis (2), 
mixed bacterial and fungal infection (4), Pneumocystis carinii (2) and unconfirmed 
organisms (4).
In  a  study by Jha  V et  al  (1999),  carried  out  at  the Postgraduate  Institute  of 
Medical Education and Research, Chandigarh, 39 episodes of infection were recorded in 
34 patients over a period  1.5 years. M. tuberculosis was isolated during 10 episodes, 
pyogenic bacteria and Pneumocysitis carinii in 6 each, candida in 4, aspergillus in 3, 
CMV in 3 and nocardia and mucor in 1 each34. More than one organism was isolated 
during 5 episodes. They concluded that tuberculosis and P. carinii pneumonia were the 
most  common  non  pyogenic  infections  in  the  first  year  after  transplantation  in 
developing countries. 
In a study conducted at All India Institute of Medical Sciences, New Delhi, By 
Vikram kalra et al. (2002)31, 40 renal transplant recipients reported with 44 episodes of 
pulmonary infection during the study period. Out of the 44 episodes of pulmonary 
infection evaluated, single causative organism could be found in only 24 (54.5%) 
episodes and multiple etiologies were found in 15 (34.1%) episodes. No definitive cause 
could be found in 5 episodes. Out of 57 organisms isolated in the 44 episodes, 20 (45.4 
%) were bacteria, 16 (36.3 %) each were M. tuberculosis and fungus, 3 were CMV 
infection and 2 were nocardia. 
Spectrum of pulmonary infection in Indian studies are given in the following 
table. 
Table No.2 Spectrum of pulmonary infections in Indian studies (%)31
Modi ‘98
AIIMS
Jha R ‘99
Hyderabad
Jha V ‘99
PGI
Menon‘02
K.E.M.
Vikram 
Kalra‘03
AIIMS
Episodes 18 27 39 16 44
Bacteria 27.7 25.9 33.3 25 45.4
Nocardia 5.5 7.4 2.5 - 4.5
M. tub 50.0 37.0 30.7 - 36.3
P. carinii - 7.4 15.3 6.2 27.2
Fungi 11.1 22.2 17.9 - 9.0
CMV 5.5 7.4 - 12.5 6.8
While focusing on infectious etiologies, in many instances, empiric, and broad 
spectrum antimicrobial therapies require to be instituted while a full  evaluation is in 
progress, but these broad spectrum regimens cannot encompass all possible causative 
agents without producing unnecessary toxicity and expense. Failure to treat the causative 
process  promptly  can be  devastating,  particularly  if  the  process  is  an infection  in  a 
severely immunodeficient patient like an allograft recipient32. Thus, it is important to 
establish the specific causative processes of a patent’s pulmonary disease so that specific 
therapy can be instituted in a manner that  promotes optimal  efficacy and minimises 
toxicity and expense. 
Various methods have been used as the diagnostic procedures to identify the 
microorganisms. These include sputum analysis, serology, blood culture, gastric 
aspiration33 (for the analysis of tuberculosis), radiology (x ray, high resolution 
computerized tomography), fiberoptic bronchoscopy (BAL, mucosal brushing), 
transtracheal aspiration. Each method has its own advantages and shortcomings. Of 
these methods, fiberoptic bronchoscopy (FOB) is one of the most routinely used and 
accurate diagnostic aid.
MATERIALS AND METHODS
Study design               :  Prospective Cohort Study
Subjects and settings :  Renal transplant patients being followed 
up at the Department of Nephrology, 
Department of Thoracic Medicine Madras 
Medical College,          Government  General 
Hospital.
Duration of study       : October 2007 - October 2009
Inclusion criteria
Transplant recipients attending the renal transplant clinic were included if they 
developed clinical and radiological (X ray chest or chest CT) features suggestive of 
pulmonary infection, 
Exclusion criteria
1) Patients who have received antibiotics for more than 48 hrs.
2) Patients who are too seriously ill to undergo BAL procedure with
i)  Unstable myocardium
ii)  Uncorrectable hypoxemia/hypercapnia
iii)  Uncorrectable bleeding tendency
Study procedure 
The study was conducted after obtaining approval from the Institutional Ethical 
Committee  of  Madras  Medical  College;  Government  General  Hospital,  Chennai. 
Patients seeking medical  treatment at  Department of  Nephrology and Department  of 
Thoracic medicine wards with manifestations of respiratory infections were explained 
about  the  study  purpose  and  procedure.  After  getting  written  informed consent  and 
taking inclusion and exclusion criteria into consideration, patients were included in the 
study. The selected patients were admitted in nephrology ward of Government General 
Hospital, Chennai. .
All patients underwent a comprehensive clinical assessment, which included a 
detailed history and a thorough physical examination. The patients were evaluated in 
detail for the history of present illness symptoms like fever, cough, haemoptysis, 
dyspnea, chest pain, history of previous chest infection (pre and post transplant), details 
of immunosuppression, past history of acute rejection and its therapy, recent IV 
antibiotics. History of other risk factors like diabetes (pre and post transplant) and 
serological virology status hepatitis B and C, and CMV. (Appendix I)
 
Clinical examination
 A detailed clinical examination was carried out. Each patient was assessed for 
anemia, cyanosis, lymph nodes, scars and sinuses and icterus. Special emphasis was 
given to the respiratory system for respiratory rate, findings related to pneumonia or 
pleural effusion and evidence of respiratory distress.
Investigations  
The investigations included general laboratory tests, radiological assessment of 
the pulmonary lesion as well specific investigations to isolate the causative organisms.
 a)  Laboratory tests
This included Blood haemoglobin, complete blood counts, ESR. serum 
biochemistry included blood sugar, renal function test (blood urea, serum creatinine), 
liver function test (serum bilirubin, SGOT, SGPT, total proteins, albumin, globulin )
b) Sputum
Sputum  specimen  was  received  from  the  patient  on  first  day  of  admission 
submitted for direct smear examination by Gram’s stain, staining for demonstration of 
fungal  elements  using KOH mount.  Three specimen of  sputum, one on first  day of 
admission and two on second day of admission including a early morning sample was 
collected and submitted for Ziehl-Nielson stain (Z-N) for acid fast bacilli (AFB) 
c) Fiberoptic bronchoscopy and bronchoalveolar lavage
On second day of admission, patients undergoing bronchoscopy were explained 
the nature of the procedure, its possible benefits and risks, in detail. Another written 
informed consent was obtained and the patient was kept fasting at least 4 hours prior to 
the procedure. Inj.Glycopyrrolate 0.2mg i.m was given as premedication. The fiberoptic 
bronchoscope was introduced intranasally after topical anaesthesia lignocaine. After 
routine examination of the tracheobronchial tree, the bronchoscope was wedged into a 
segmental bronchus supplying an area of radiographic abnormalities or into the middle 
and lingual lobe in case of bilateral diffuse infiltration of the lung. Bronchoaveolar 
lavage was then performed by segmental instillation and suctioning of 20 ml volumes of 
physiologic saline solution. The procedure was repeated ten times and the fluids were 
then pooled. 
The BAL specimen was submitted for the following studies:
Gram’s stain and aerobic bacterial cultures, both qualitative and quantitative. For 
quantitative cultures of the lavage specimen, the fluid was diluted with normal saline 
from 1:102 to 1:104 times. It was then inoculated onto culture media viz. blood agar, 
MacConkey’s agar and chocolate blood agar. Thioglycollate broth was also inoculated if 
the results of culture plates were negative. A colony count >104cfu/ml was considered 
significant39. Z-N stain for AFB and BACTEC 460 method for Mycobacterial culture. 
Direct examination for fungal elements using relevant stains and fungal culture and 
GMS stain to identify Pneumocystitis carinii
Treatment
All  patients  were  treated  with  empirical  antibiotics  regimen  according  to  the 
presenting clinical features. The treatment was modified as warranted either by the need 
of the patient  or  depending on the results of investigations performed as part of the 
study. Patients not responding to treatment were treated with empirical Anti-tuberculosis 
and/or Anti-fungal drugs.
 Response to therapy 
 The response to therapy was monitored on the basis of clinical improvement and 
radiological resolution.
The data  collected  were  subjected  to  basic  statistical  analysis  and appropriate 
interpretations were drawn.
RESULTS
During the 2 year period, from October 2007 to October 2009, 29 renal transplant 
patients reported with respiratory symptoms were admitted for inpatient care. Of the 29 
patients, 27 reported once, 1 reported twice and another thrice. A total of 32 episodes of 
respiratory infection were studied.23 patients were male and 6 were females.
The age range was 18 years to 53 years of age and the mean age of the patients was 31.8 
years
The age and sex distribution is given in the following table.
Table 3 - Age and Sex Distribution
Age Group Total
<30years >30 years
Male 11 12 23
Female 2 4 6
Total 13 16 29
29 patients in the age range of 18 to 53 were divided into two groups. One was < 
30 years and the other was > 30 years.
Table 4 - Source of Donor kidney
Age Group
Total
<30years >30 years
Live
Male 10 11 21
Female 1 3 4
Cadaver
Male 1 1 2
Female 1 1 2
Total 13 16 29
25 (86.2%) patients out of 29 had received the organ from a live related donor and 
4 (13.8%) had received from cadavers.
Further analysis was done for 32 episodes of respiratory illness among 29 renal 
patients.
Table 5 - Time of Respiratory Infection Post Transplant
Period N = 32(%)
Less than 1 month 2 (6.3)
1 month to 6 months 9 (28.1)
6 months to 1 year 5(15.6)
1 to 2 years 4(12.5)
More than 2 years 12(37.5)
While analyzing the time of infection since transplantation, it was found that 2 
(6.3%) patients presented less than a month from transplant surgery, 9 (  28.1% ) patients 
from 1 month to 6 months, 5 (15.6%) patients from 6 months to 1 year, 4 ( 12.5%  ) 
patients from 1 to 2 years and 12 (37.5%) patients more than 2 years since transplant 
surgery. Out of this the shortest period was 4th post operative day and the longest being 9 
years after transplant surgery.
Table 6 - Risk Factors
Condition N=29(%)
H/O Acute rejection 11(37.93)
PTDM 4(13.8)
H/O CMV infection 3(10.34)
H/O Hepatitis
B 1(3.4)
C 2(6.9)
Pre transplant DM 1(3.4)
No identifiable risk factors 7(24.13)
TOTAL 29(100)
On analyzing risk factors for developing respiratory infections, history of acute 
graft rejection was found in 11 patients (37.93%) and had received anti rejection therapy 
with pulse Methyl prednisolone. 4 patients (13.8%)had Post transplant diabetes mellitus 
and one (3.4%) had diabetes mellitus prior to transplant. Prior history of cytomegalo 
virus infection was present in 3 patients (10.34%). 3 patients (10.3 %) were suffering 
from hepatitis,  2  from Hepatitis  C and 1  from Hepatitis  B infection.  There  was no 
identifiable risk factors in 7 patients(24.13%).
Table 7- Immunosuppressive Therapy Frequency
Immunosuppressive Therapy N = 29 (%)
CsA+S+A 22 (75.86%)
CsA+S 1 (3.45%)
A+S 1(3.45%)
Tacrolimus+MMF+S 4 (13.79%)
CsA+MMF+S 1(3.45%)
TOTAL 29 (100%)
CsA – Cyclosporin A, S- prednisolone, 
A- Azathioprine, MMF- Mycophenolate Mofetil
On analyzing the immunosuppressive therapies administered to transplant 
receipients, It was found that 22 patients (75.86%) were under triple immunosuppressive 
therapy which included Cyclosporin A, Prednisolone and Azathioprine. All 4 patients 
(13.79%) who received their donor organ from cadaver were given Tacrolimus, MMF 
and Prednisolone.
Table 8 - Chest Symptomatology
Symptoms N=32(%)
Fever 27(84.3)
Cough Expectoration 22(68.75)
Loss of Appetite 11(34.3)
Breathlessness 11(34.3)
Weight loss 6(18.75)
Chest pain 5(15.6)
Hemoptysis 2(6.2)
Fever was the chief presenting complaint in 27 episodes (84.3%). Cough with 
expectoration was present in 22 (68.75%) episodes. shortness of breath was present in 11 
episodes (34.3%). Loss of appetite was present in 11 episodes (34.3%) and of which 6 
episodes (18.75%) presented with significant weight loss. 5 episodes (15.6%) presented 
with chest pain and 2 episodes (6.2%) had hemoptysis.
The mean duration of symptoms before admission during the study was 6.12 days. 
One patient had developed symptoms on the 4th post operative day of the transplant 
while 1 patient reported after a month of symptoms to the hospital.
Table 9 - Radiological Manifestations at presentation
Radiological Features N-32(%)
Air space opacities/ Consolidation 23(71.87)
Pleural effusion 4(12.4)
Nodules 1(3.1)
Fibrocavity 1(3.1)
Miliary 1(3.1)
Normal 2(6.2)
TOTAL 32(100)
On analyzing radiological manifestations of pulmonary infection, 23 ( 71.87%  ) 
patients had presented as air space opacities / consolidation, 4 ( 12.4%  ) patients  had 
presented as pleural effusion, 1 patient (3.1%) each of miliary nodules and Fibro cavity 
and was normal in 2 ( 6.2% ) patients.
Microbiology
Sputum
Sputum was available for test in only 25 patients. Sputum specimens in 17 
episode were positive for gram negative bacilli, in 8 with gram positive cocci, 1 with 
gram positive bacilli and in one episode both gram  positive bacilli and gram positive 
cocci. KOH mount positive for fungal elements in one episode.
Sputum ziehl-neelson staining for Acid fast bacilli was positive in 2 patients (6.25 
%)
Table 10 - Sputum Bacterial Culture
N=32(%)
Pseudomonas 4(18.18)
Klebsiella 4(18.18)
Pseudomonas+Klebsiella 1(3.12)
Staph.aureus 1(3.12)
Mycobacterium tuberculosis 2(6.25)
Candida 1(3.12)
No Sputum available 7 (21.87)
No identifiable Organism 12(37.5)
TOTAL 32(100)
Sputum for bacterial culture grew pseudomonas and klebsiella species in 4 
patients (18.18%) each and one patient (3.12%) grew both pseudomonas and klebsiella. 
Staphylococcus aureus species was isolated from another patient. Sputum fungal culture 
grew candida species in one patient. Sputum bacterial culture showed no growth in 12 
patients (37.5%).
BAL (Bronchoalveolar Lavage)
Broncho alveolar lavage was done in 30 episodes excluding 2 patients who were 
sputum smear positive for AFB. 
The diagnostic yield of BAL is given in the following table.
Table 11- Diagnostic Yield of BAL Microbial Analysis
Diagnostic yield N=32(%)
Single organism 22(68.75%)
Multiple organism 5(15.625)
No growth 3 (9.375)
BAL not done 2(6.25)
TOTAL 32(100)
The Diagnostic yield of BAL, 22 episodes with single organism infection and 5 
episodes with multiple organisms infections were made out. In 3 episodes no organisms 
could be isolated.
BAL specimens in 19 episodes were positive for gram negative bacilli, in 8 with 
gram positive cocci,  2 with gram positive bacilli  and another 2  episodes both gram 
positive bacilli and gram positive cocci. KOH mount positive for fungal elements in 3 
episodes.BAL Ziehl-neelson staining for Acid fast bacilli was positive in 7 patients.
Table 12 - Spectrum of Micro organisms isolated from BAL fluid
Organism
N=30 %
Single
Organism
N =22
Multiple
Organism
N=5
No 
organism
Bacteria
Pseudomonas
8 26.6%
Klebsiella
2 6.6%
Pseudomonas+ 
Klebsiella
2
6.6%
Staph.aureus
1 3.33%
Acinetobacter 
+Klebsiella
1
3.33%
Nocardia
1 3.33%
CONS
1 3.33%
Mycobacteria
6 20%
+ Flavobacterium Sps
+ Pseudomonas
1
3.33%
Fungus
P.carinii
1 3.33%
Candida
2 6.6%
Aspergillus + E.coli 1
3.33%
No organisms 
isolated 3 10%
TOTAL 22 5 3 100%
Bacterial Culture
In BAL bacterial culture, 16 episodes showed evidence of bacterial infection and a 
total of 22 bacterial species were isolated. In 5 episodes multiple bacterial organisms 
were  isolated  and  in  rest  single  organism was  isolated.   Of  the  multiple  infections, 
Pseudomonas coinfection with Klebsiella   were present  in 2 episodes,  Acinetobacter 
coinfection with Klebsiella were present in one episode. Mycobacterial infection with 
Flavobacterium  species  and  Pseudomonas  in  one  episode  and   Aspergilus  flavus 
infection with E.coli in one episode.
In the rest, single organism was present in 13 episodes. Of it  most common was 
pseudomonas  species  grown  in  8  (26.6%)  episodes,  Klebsiella  in  2  episodes  and 
Staphylococcus.aureus,  Nocardia,  Coagulase negative staphylococcus one each.  BAL 
bacterial culture in 12 episodes showed no growth.
BAL Ziehl - Nielson Stain
BAL Ziehl-nielson staining for acid fast bacilli was positive in total of 7 patients. 
Isolated Mycobacterial infection in 6 patients and in one patient it was associated with 
Flavobacterium   and  Pseudomonas  organisms.  These  were  confirmed  with  BAL 
BACTEC 460 method.
Grading of BAL AFB was as follows, 1+ in 5 patients and one each of 2+ and 3+.
BAL Fungal Culture
IN  BAL  fungal  culture,  Candida  species  were  isolated  in  2  patients  and 
Aspergillus in one patient.BAL GMS stain for Pneumocystitis Jeruvici was positive in 
one patient.
No organisms were isolated in 3 episodes.
Table 13 - Spectrum of Microbes in Relation to Duration Post Transplant Surgery
Period
Bacterial Myco
bacterium
Fungal No 
Organism
Isolated
Ps Kl Ps+ Kl S.a Fl E N C Kl+A
Can
dida
Asper
gillus PCP
Less 
than 1 
month 1 1
1 month 
to 6 
months 3 1 1 1 1 2 1 1
6 
months 
to 1 year 1 0 1 1 1 1
1 year – 
2 year
1 1 1 1
More 
than 2 
year 4 1 1 5 1
Ps - Pseudomonas-,Kl - Klebsiella, Ps + Kl - Pseudomonas+Klebsiella, S.a Staph.aureus, 
Fl - Flavobacterium, E - E.coli, N - Nocardia, C - Coagulase negative staphylococcus 
aureus, Kl+ A - Klebsiella+Acinetobacter
On analysis  of  spectrum of  respiratory  infections  in  relation  to  duration  post 
transplant following observations were made.
In period less than a month, two (6.25%) episodes of respiratory infections were 
observed in this study and one was a bacterial infection with klebsiella species and no 
organism could be isolated in the other.
9 episodes (28.125%)in between 1 month and 6 months of transplant surgery. Of 
these  3  episodes  were  with  multiple  organisms.  7  were  bacterial  infections,  2  were 
mycobacterial infections and 1 fungal infection. The only episode of PCP infection of 
this study also presented during this period.
5 (15.625%) episodes presented during the period 6 months to 1 year. Of these 2 
were  with  multiple  organisms.  It  constituted  of  3  bacterial,  1  mycobacterial  and  1 
Aspergillus flavus infection. This fungal infection was a multiple infection with E.coli.
4 (12.5%) episodes presented between 1year and 2 years of transplant surgery. 1 
bacterial, 1 mycobacterial and 1 candida infection. No organism could be isolated in one 
episode.
12 (37.5%) episodes after 1 year of transplant surgery. Of these 6 were bacterial 
and 5 were mycobacterial.  In  one episode  no organism could be isolated.  The only 
episode  of  nocardial  infection  in  this  study  presented  in  14th month  post  transplant 
surgery and this patient was suffering from hepatitis, a known risk factor for nocardial 
infection.All the episodes of multiple infections ( 5 episodes) present within 1 year of 
duration since transplant surgery and of the total 32 episodes, No organism could be 
isolated in 3 (9.375%) episodes.
Table 14 - Spectrum of Respiratory infections in Relation to Radiographic Findings
Air 
space 
opacities
/Consoli
dation
Pleural 
effusion
Nodule
s
Fibro
cavity
Miliar
y
Norma
l Total
Bacterial 
Infection
12 3 1 16
Mycobacteriu
m Tuberculosis
6 1 1 1 9
Aspergillus 1 1
Candida 2 2
PCP 1 1
No definite 
diagnosis
1 1 1 3
TOTAL 23 4 1 1 1 2 32
On  analysis  of  spectrum  of  microbes  in  relation  to  radiographic  findings, 
following observations were made. Of the 16 episodes of bacterial infections, 12(75%) 
episodes presented with radiologic feature of air space opacities/consolidation, 3 with 
pleural effusion and 1 with nodular opacity.  Nocardial infection presented as nodular 
opacity. 
Mycobacterial infection presented with following radiological findings. 6 episodes 
presented with features of air space opacity and one each with features of fibro cavity, 
miliary pattern. 
Fungal infections and Pneumocystitis pneumonia presented with features of air 
space opacity.
Table 15 - Spectrum of Respiratory Infections in Relation to Immunosuppressive 
Therapy
Immunosuppressive 
Therapy
Bacterial Myco
bacterium
Fungal
P
s Kl Ps+Kl S.a
F
l E N C Kl+A
Can
dida
Asper
gillus PCP
CsA+S+A 6 2 1 1 1 1 1 8 1 1 1
CsA+S 1
A+S 1
Tacrolimus+MMF+S 1 2 1
CsA+MMF+S 1
Ps - Pseudomonas-,Kl - Klebsiella, Ps + Kl - Pseudomonas+Klebsiella -3, S.a -Staph.aureus, Fl - 
Flavobacterium, E - E.coli, N - Nocardia, C - Coagulase negative staphylococcus aureus, Kl+ A - 
Klebsiella+Acinetobacter  CsA  –  Cyclosporin  A,  S-  prednisolone,  A-  Azathioprine,  MMF- 
Mycophenolate Mofetil
On analysis  of  respiratory  infection  in  relation to  immunosuppressive therapy, 
following observations were made.Respiratory infections either bacterial, mycobacterial 
or fungal were common in patients with triple drugs immunosuppressive therapy with 
Cyclosporin-A, Prednisolone, and azathioprine. Out of the 9 Mycobacterial infections, 8 
were present in patients on cyclosporine A containing immunosuppressive therapy.
Table 16 - Drug Sensitivity Pattern in Bacterial culture
Drugs N=18 (%)
Ciprofloxacin 14(77.77)
Amikacin 12(66.66)
Cefaperazone sulbactum 9(50)
Ofloxacin 6(33.33)
Gentamycin 6(33.33)
Piperazaline-Tazobactum 3(16.66)
Cefatoxime 3(16.66)
On analysis of drug sensitivity pattern of bacterial culture, following observations 
were made. Ciprofloxacin was sensitive in 14 out of 18 episodes (77.77%) of bacterial 
infections. In 12 out of 18 episodes (66.66%) Amikacin was sensitive and Cefaperazone 
sulbactum sensitive in 9 episodes (50%) of bacterial infections.
DISCUSSION
Bacteria,  known  to  be  the  most  common  cause  of  pneumonia  in  the 
immunocompromised  individual3,  have  been  found  to  be  the  major  cause  of  post 
transplant  pulmonary  infections  in  other  studies  too.  In  other  Indian  studies  the 
incidence of bacteria has been found to range from 25% to 33.3%. In our study, bacteria, 
account for 62.8% of all the organisms diagnosed (22 out of 35 organisms). The exact 
incidence  of  bacterial  pneumonia  among  transplant  recipients  is  difficult  to  assess 
because broad spectrum antibiotics are empirically started early upon admission. Munda 
et al9 found that 69.5% of the causative organisms in 46 episodes of post transplant 
pulmonary  infection  were  bacteria.  This  high  incidence  has  been  attributed  by  the 
authors  to  their  use  of  transtracheal  percutaneous  puncture  for  the  isolation  of  the 
organism. In the study by Webb12 et al, 52 organisms were isolated from the 44 episodes. 
They found 68.8% of the organisms to be bacteria. In the study by Modi et al in AIIMS, 
found bacterial infection to be 27.7% in 18 episodes of respiratory infections in post 
renal transplant patients. Jha V et al quoted a bacterial infection incidence as 33.3% and 
Vikram kalra et al found the bacterial infections to be 45.4%.
In India, tuberculosis being an endemic disease poses a formidable challenge to 
the  clinician  dealing  with  transplant  recipients  despite  the  advances  in  diagnostic 
facilities and chemotherapy29. This is expected since the prevalence of tuberculosis in 
general population in India is higher. Lung tuberculosis has been reported to occur with 
10-25 times higher  frequency in immunosuppressed patients6.  Recent  Indian data34,35 
shows a higher incidence of pulmonary tuberculosis in this group of patients, ranging 
from 30-50%.  Modi  et  al  35  reported  Tuberculosis  incidence  of  50%. Jha  V et  al34 
reported an incidence of 30.7%. Vikram kalra et al 31, found the incidence of tuberculosis 
in post renal transplant patients to be 36.3%.As quoted in the previous study, this is 
probably because of the use of bronchoscopy in the isolation of the organism in the 
recent studies. Our study reported an incidence of 28.12% of pulmonary tuberculosis in 
the renal transplant recipients. The time range for development of tuberculosis infection 
was from 2.7 months to 8.7 years, with a mean of 3.38 years. 7 out of the 9 tuberculosis 
patients developed the illness in less than 6 years period from transplant surgery. All 
these 7 patients were on triple immunosuppressive drugs (Cyclosporine, Azathioprine 
and steroids). Of the 2 developing tuberculosis beyond 6 years duration, 1 was on non 
cyclosporine containing immunosuppressive therapy (Azathioprine and steroids) and the 
other on triple immunosuppressive drugs. This in accordance with the study by John et 
al, CMC vellore  determining a timetable for post transplant infections in the tropics36 
concluded  that  most  patients  on  CsA  who  are  likely  to  develop  post  transplant 
tuberculosis will have developed the disease by six years.
P.jeruvucii  is  an  opportunistic  pathogen  especially  observed  in  patients  with 
impaired cellular immunity37. In our study, there was one episode (2.85%) of PCP. It 
presented in 5th month, Post transplant surgery. In recent studies in India, the incidence 
of PCP among this group of patients was from 6% to 27% 
Multiple organism infections were noted in 5 episodes (14.28%). 4 of this had 2 
organisms and one case had 3 organisms as etiology. Tuberculosis with Pseudomonas 
and flavobacterium infection &  Aspergilosis with E.coli was noted one each and the 
other 3 were mixed bacterial infections. 2 cases with pseudomonas & Klebsiella and one 
case  with Acinetobacter  and klebsiella.  More  than one  organism being the  cause  of 
infection has been seen in other studies too. Jha R et al 30 found 4 cases to have a mixed 
aetiology of the 27 cases they studied. In the study by Jha V et al34,  more than one 
organisms were implicated in 5 episodes out of 39. Out of these 5, the second organism 
was diagnosed only on autopsy in 3 cases and on BAL in the other 2. Heurlin et al15 
could isolate multiple organisms in 6 out of 34 cases. In 4 of these 6 instances, the 
isolation was on bronchoscopy. Munda et al9 found mixed infections in 11 cases of the 
46 they studied. In their study only 4 patients underwent bronchoscopy, more than one 
organism being isolated in 1 patient out of these 4. In the study by, Vikram kalra et al 31 
,Out of the 44 episodes of pulmonary infection evaluated, multiple etiologies were found 
in 15 (34.1%) episodes. based on BAL .Thus, it appears that the use of BAL may be an 
important factor also in isolation of more than one organism and establishing a multiple 
aetiology.
Herpes, Influenza, parainfluenza and adenovirus are the group of viruses which 
causes respiratory tract infections in renal transplant recipients. Among these CMV is 
the most frequent pathogen encountered18,19. It frequently occurs 1-4 months after 
transplantation, when both allograft rejection and intensive immunosuppressive 
treatment occur. The clinical onset of CMV pneumonia is usually insidious with slowly 
progressing, relapsing fever, alternating between afebrile and 40o C along with fatigue. 
CMV infection was not well recognised among renal transplant recipients in tropical 
countries because of lack of proper diagnostic facilities21, 38. 
Our study did not include investigations related to viral etiology due to lack of 
facilities to identify and isolate the same in our institution.
CONCLUSION
The present study concluded that:
1. Fever and cough with expectoration were the most common clinical presentation.
2. Bacteria were the most prevalent cause of post transplant pulmonary infection. 
3. Pseudomonas  and  klebsiella  were  the  most  common bacterial  species  causing 
respiratory infections among renal transplant recipients.
4. Tuberculosis also has a high incidence in renal allograft recipients in our set up. 
5. Mixed infection is common among renal transplant recipients and search for the 
aetiologic agent should not stop at the isolation of one organism especially if the 
response to therapy against a single aetiologic agent is partial and/or delayed. The 
presence of more than one organism should be conclusively ruled out.
6. Bronchoalveolar lavage is one of the most important diagnostic aids and has a 
high diagnostic yield.
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ABBREVIATION
BAL - Bronchoalveolar Lavage
GMS Stain - Gomori methenamine silver stain
CMV - Cytomegalo virus
Z-N stain - Ziehl – Nielson stain
AFB - Acid Fast Bacilli
CT chest - Computerised Tomography chest
CXR - Chest  X-Ray
SGOT - Serum Glutamate Ornithine Transaminase
SGPT - Serum Glutamate Pyruvate Transaminase
KOH - Potassium Hydroxide
PTDM - Post Transplant Diabetes mellitus
CsA - Cyclosporin A
MMF - Mycophenolate Mofetil
APPENDIX I
QUESTIONNIERE Case No.
Name: Age: Sex:
Height: Weight: BMI: Occupation:
Date of admission: Date of Transplant Surgery:
Original disease: Source of organ:
Living Conditions:
City/ Rural Source of Water:
Type of House
Ventilation condition
Sanitation Toilet habits:
Location of kitchen Fuel for cooking:
H/O present illness 
Symptoms Duration
Cough/expectoration 
Fever
Breathlessness
Chest pain
Hemoptysis
H/O past illness
H/O previous infections: CMV, TB, HCV, HBV
H/O graft rejection (creatinine >1.5mg %):
H/O Anti-rejection therapy:
Diabetes Mellitus
DRUGS HISTORY:
Current medication:
Recent medication changes:
Immunosuppressive Therapy:
Compliance of Therapy:
RESULTS
FOB Report:
Blood Report Sputum Report BAL Report
Radiology

